title: Aberrant expression of myeloid and B cell markers in an aggressive multiple-site myeloid sarcoma.
authors.forename: Georgia D
authors.initials: GD
authors.lastname: Kaiafa
authors.forename: Vasilios
authors.initials: V
authors.lastname: Perifanis
authors.forename: Michael D
authors.initials: MD
authors.lastname: Diamantidis
authors.forename: Olga
authors.initials: O
authors.lastname: Giouleme
authors.forename: Virginia
authors.initials: V
authors.lastname: Voulgaridou
authors.forename: Eleni
authors.initials: E
authors.lastname: Beretouli
authors.forename: Anna
authors.initials: A
authors.lastname: Kalogera-Fountzila
authors.forename: Vassiliki
authors.initials: V
authors.lastname: Kaloutsi
mesh_terms: D001402:B-Lymphocytes / Q000378:metabolism* / Q000473:pathology; D014408:Biomarkers, Tumor / Q000235:genetics* / Q000378:metabolism; D005260:Female; D015973:Gene Expression Regulation, Leukemic; D006801:Humans; D008159:Lumbar Vertebrae; D008875:Middle Aged; D022423:Myeloid Cells / Q000378:metabolism* / Q000473:pathology; D009361:Neoplasm Invasiveness; D009378:Neoplasms, Multiple Primary / Q000235:genetics* / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D023981:Sarcoma, Myeloid / Q000235:genetics* / Q000276:immunology / Q000378:metabolism / Q000473:pathology
chemical_list: D014408:Biomarkers, Tumor